91É«Ç鯬

Severe covid-19 symptoms linked to more than 1300 genetic variants

Hundreds of genetic variants may influence your risk of becoming severely ill with covid-19, a discovery that could lead to more targeted treatments or even tests that assess a person's likelihood of complications
A genetic test in a laboratory
A genetic test in a laboratory
Haydar Dogramaci/Getty Images

More than 1000 genes may contribute to a person’s risk of developing severe covid-19, on top of life circumstances such as their age, ethnicity and any health conditions.

Most of the genes, discovered in a study of more than 1 million people, affect the functioning of two kinds of immune cell.

If the results are confirmed, they could inform a test that assesses a person’s risk of getting badly ill with covid-19, says at the University of Sheffield, UK.

“We know there are young people who are otherwise fit that get severe covid,� he says. “We are trying to get at the genetic determinants that put people at risk irrespective of the more obvious things.�

Cooper-Knock’s team used artificial intelligence to analyse results from a global data set called the , a genetics project run by a group of researchers and companies.

The team looked at which genetic variants were more common in about 5100 people who died or needed respiratory support because of covid-19, compared with about 1.4 million people who never tested positive for the infection. None of the participants was vaccinated against covid-19.

The research group found 1370 gene variants that were linked to covid-19 severity, with these same variants coming up again when checked against two similar data sets.

These variants accounted for three-quarters of the participants’ genetic risk for severe covid-19, with the remaining one-quarter of the risk being unknown, according to the team.

Next, the team cross-checked the results with information on which genes are normally active in 19 different types of cell in healthy lungs. This showed that immune cells called natural killer cells and T-cells are key in controlling whether covid-19 becomes severe.

Before the results can be turned into a commercial genetic assay, a prototype would need to be tested further, says Cooper-Knock. “We would sequence [participants] before they have covid-19, assign them into risk groups and make predictions.�

Such a test may be less accurate if used on vaccinated people, as genetic susceptibility is less relevant if you have the protection of a vaccine, says at the University of Oxford.

Nevertheless, the findings shed light on the mechanisms involved in severe covid-19, which could lead to new treatments, he says. “The main importance is in identifying new therapy options,� he says.

Cell Systems

Sign up to our free 91É«Ç鯬 Check newsletter that gives you the health, diet and fitness news you can trust, every Saturday

Topics: coronavirus / covid-19 / Genetics / pandemic / SARS-CoV-2